CRYSTALLINE FORM OF A BET-INHIBITOR AND MANUFACTURE THEREOF
申请人:ORION CORPORATION
公开号:US20220204493A1
公开(公告)日:2022-06-30
The present invention relates to crystalline form 1 of 6-(3, 5-dimethylisoxazol-4-yl)-7-methoxy-3-methyl-1-(pyridin-2-ylmethyl)quinolin-2(1H)-one (I) and to a method of manufacture thereof. Compound (I) is a BET inhibitor useful in the treatment of cancer.